Published in J Clin Psychopharmacol on December 01, 2004
Compulsivity in anorexia nervosa: a transdiagnostic concept. Front Psychol (2014) 0.95
Apathy symptoms modulate motivational decision making on the Iowa gambling task. Behav Brain Funct (2012) 0.77
Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLoS Genet (2013) 1.68
Frontal lobe dysfunction in pathological gambling patients. Biol Psychiatry (2002) 1.65
Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum Mol Genet (2004) 1.20
Understanding obsessive-compulsive disorder: focus on decision making. Neuropsychol Rev (2006) 1.14
Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. Eur J Hum Genet (2005) 1.13
Executive dysfunctions in obsessive-compulsive patients and unaffected relatives: searching for a new intermediate phenotype. Biol Psychiatry (2010) 1.11
Basal-corticofrontal circuits in schizophrenia and obsessive-compulsive disorder: a controlled, double dissociation study. Biol Psychiatry (2003) 1.09
Neuropsychological investigation of decision-making in anorexia nervosa. Psychiatry Res (2004) 1.08
In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. Neuroimage (2008) 1.08
Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Eur Neuropsychopharmacol (2005) 1.07
Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet (2002) 1.07
Health-related quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Clin Psychiatry (2007) 0.97
Obsessive compulsive disorder among idiopathic focal dystonia patients: an epidemiological and family study. Biol Psychiatry (2002) 0.95
Approximate entropy of respiratory patterns in panic disorder. Am J Psychiatry (2004) 0.94
Present and lifetime comorbidity of tobacco, alcohol and drug use in eating disorders: a European multicenter study. Drug Alcohol Depend (2008) 0.91
Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. Am J Psychiatry (2014) 0.90
Self-injurious behavior and attempted suicide in purging bulimia nervosa: associations with psychiatric comorbidity. J Affect Disord (2007) 0.89
Executive functioning in anorexia nervosa patients and their unaffected relatives. Psychiatry Res (2012) 0.88
Low social interactions in eating disorder patients in childhood and adulthood: a multi-centre European case control study. J Health Psychol (2012) 0.88
Fat mass and obesity-associated gene (FTO) in eating disorders: evidence for association of the rs9939609 obesity risk allele with bulimia nervosa and anorexia nervosa. Obes Facts (2012) 0.87
Neurosteroid secretion in panic disorder. Psychiatry Res (2003) 0.87
Investigation of the serotonin transporter regulatory region polymorphism in bulimia nervosa: relationships to harm avoidance, nutritional parameters, and psychiatric comorbidity. Psychosom Med (2006) 0.87
Smoking and respiratory irregularity in panic disorder. Biol Psychiatry (2004) 0.87
Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome. J Clin Psychopharmacol (2002) 0.86
Decision-making functioning as a predictor of treatment outcome in anorexia nervosa. Psychiatry Res (2006) 0.86
Motor inhibition and cognitive flexibility in eating disorder subtypes. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.85
Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. Neuropsychopharmacology (2005) 0.85
Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients. Neuropsychopharmacology (2006) 0.84
Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders. Int Clin Psychopharmacol (2009) 0.83
Artificial neural network model for the prediction of obsessive-compulsive disorder treatment response. J Clin Psychopharmacol (2009) 0.82
Novel antidepressants and panic disorder: evidence beyond current guidelines. Neuropsychobiology (2010) 0.81
Anticipation of age at onset of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder. Psychiatry Res (2002) 0.81
Respiration in children at risk for panic disorder. Arch Gen Psychiatry (2002) 0.81
Cardiorespiratory response to physical exercise and psychological variables in panic disorder. Rev Bras Psiquiatr (2011) 0.80
Case-control and combined family trios analysis of three polymorphisms in the ghrelin gene in European patients with anorexia and bulimia nervosa. Psychiatr Genet (2006) 0.80
The somatic marker affecting decisional processes in obsessive-compulsive disorder. Cogn Neuropsychiatry (2011) 0.79
No association between obsessive-compulsive disorder and the 5-HT(1Dbeta) receptor gene. Am J Psychiatry (2002) 0.78
Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study. J Clin Psychopharmacol (2004) 0.78
Serotonergic modulation of the balance system in panic disorder: an open study. Depress Anxiety (2003) 0.77
Anxiety sensitivity and 35% CO2 reactivity in patients with panic disorder. J Psychosom Res (2003) 0.77
Selective serotonin re-uptake inhibitors beyond psychiatry: are they useful in the treatment of severe, chronic, obstructive pulmonary disease? Depress Anxiety (2004) 0.76
Supporting tools in psychiatric treatment decision-making: sertraline outcome investigation with artificial neural network method. Psychiatry Res (2005) 0.76
Comparison of 35% carbon dioxide reactivity between panic disorder and eating disorder. Psychiatry Res (2004) 0.76
Novel 5'-regulatory region polymorphisms of the 5-HT2C receptor gene: association study with panic disorder. Int J Neuropsychopharmacol (2000) 0.76
Lack of relationship between CO2 reactivity and serotonin transporter gene regulatory region polymorphism in panic disorder. Am J Med Genet B Neuropsychiatr Genet (2004) 0.76
Acoustic startle response in panic disorder. Psychiatry Res (2010) 0.76
Smoking, physical activity and respiratory irregularities in patients with panic disorder. Riv Psichiatr (2013) 0.75
Vulnerability to 35% CO2 of panic disorder patients with a history of respiratory disorders. Psychiatry Res (2003) 0.75
The effect of one-week treatment with venlafaxine on 35% CO2 hyperreactivity in patients with panic disorder: an open study. J Clin Psychopharmacol (2003) 0.75
Are gender differences in antiobsessional response related to different clomipramine metabolism? J Clin Psychopharmacol (2002) 0.75
Factors of risk and maintenance for eating disorders: psychometric exploration of the cross-cultural questionnaire (CCQ) across five European countries. Clin Psychol Psychother (2010) 0.75
Bulimia nervosa, 5-HTTLPR polymorphism and treatment response to four SSRIs: a single-blind study. J Clin Psychopharmacol (2004) 0.75
Carbon dioxide-induced panic attacks and quantitative electroencephalogram in panic disorder patients. World J Biol Psychiatry (2010) 0.75
Associations of individual and family eating patterns during childhood and early adolescence: a multicentre European study of associated eating disorder factors. Br J Nutr (2008) 0.75
Emotional intelligence in panic disorder. Riv Psichiatr (2011) 0.75
Language of dyspnea in panic disorder. Depress Anxiety (2004) 0.75
Temperament, character and anxiety sensitivity in panic disorder: a high-risk study. Psychopathology (2012) 0.75